HK Stock Market Move | Ingenic Semiconductor (03223) surged over 12% after earnings, with third-quarter net profit up nearly 26-fold year-on-year, as the storage business contributed the main incremental growth.
Ingenic Semiconductor (03223) rose over 12% after earnings. As of press time, it was up 12.28% at HK$75, with a turnover of HK$15.7456 million.
Ingenic Semiconductor (03223) rose over 12% after earnings. As of press time, it was up 12.28% at HK$75, with turnover of HK$15.7456 million.
On the news front, Ingenic Semiconductor announced on the evening of October 27 that for the first three quarters, the company achieved operating revenue of RMB7.102 billion, up 106.66% year-on-year; net profit attributable to shareholders was RMB2.616 billion, up 922.95% year-on-year. In the third quarter, operating revenue was RMB3.145 billion, up 164.85% year-on-year; net profit attributable to shareholders was RMB1.419 billion, up 2,595.49% year-on-year.
Among these, the storage business contributed the main incremental growth. In the first three quarters of 2026, the company's storage chip revenue was RMB4.916 billion, up 130.73% year-on-year, with a gross margin of 56.53%; based on calculations using the interim report, third-quarter storage chip revenue was approximately RMB2.284 billion, up 206.16% year-on-year, with a third-quarter gross margin of approximately 66.3%. In addition, in the first three quarters, computing chip revenue was RMB1.752 billion, up 92.89% year-on-year, with a gross margin as high as 64.04%; analog chip revenue was RMB418 million, up 11.7% year-on-year, with a gross margin of 49.28%.
Related Articles

HK Stock Market Move | Sinotrans Limited (00598) rises over 5%; Q3 net profit attributable to shareholders up nearly 30% year on year; railway agency business volume surges

HK Stock Market Move | BAO PHARMA-B (02659) rose nearly 6%, as Chairman of the Board Liu Yanjun increased his shareholding in the company, and the clinical trial application for BJ045 injection was approved.

HK Stock Market Move | Biocytogen Pharmaceuticals-B (02315) rose more than 8% in morning trading; it will release its third-quarter results tomorrow, and institutions are bullish on further performance improvement.
HK Stock Market Move | Sinotrans Limited (00598) rises over 5%; Q3 net profit attributable to shareholders up nearly 30% year on year; railway agency business volume surges

HK Stock Market Move | BAO PHARMA-B (02659) rose nearly 6%, as Chairman of the Board Liu Yanjun increased his shareholding in the company, and the clinical trial application for BJ045 injection was approved.

HK Stock Market Move | Biocytogen Pharmaceuticals-B (02315) rose more than 8% in morning trading; it will release its third-quarter results tomorrow, and institutions are bullish on further performance improvement.






